Reported Late Wednesday, Iveric Bio Announces Pricing Of $300M Public Offering Of 13,350,000 Shares Of Common Stock At A Price Of $22.50/Share
IVERIC bio, Inc. (NASDAQ:ISEE) (the "Company"), today announced the pricing of an upsized underwritten public offering of 13,350,000 shares of its common stock at a price to the public of $22.50 per share, less underwriting discounts and commissions.
Intellia Therapeutics Announces Pricing Of ~$300M Public Offering Of 6,550,219 Shares Of Common Stock At A Price Of $45.80/Share
Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing potentially curative therapies leveraging CRISPR-based technologies, announced today the pricing of an
Reported Late Wednesday, Aura Biosciences Announces Pricing Of $80.4M Public Offering Of 6.7M Shares Of Common Stock At A Price Of $12/Share
Aura Biosciences, Inc. ("Aura") (NASDAQ:AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced the
FREYR Battery Announces Public Offering of 13.5M Ordinary Shares, No Terms Disclosed
FREYR Battery (NYSE:FREY) ("FREYR"), a developer of clean, next-generation battery cell production capacity, today announced that it plans to make a public offering of 13,500,000 of its Ordinary Shares, without
Aspen Aerogels Arranges Funds For Construction Of Statesboro Facility Via Equity Offering, Loan
Aspen Aerogels Inc (NYSE:ASPN) has priced its upsized public offering of 25.3 million shares at $9.50 per share. In addition, the…
OncoSec Announces Pricing Of $3.5M Public Offering
OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a clinical-stage biotechnology company focused on developing intratumoral immunotherapies to stimulate the patient's own immune system to target and eradicate cancer, today announced the pricing of its "reasonable best effo